India in-vitro fertilization market is forecast to grow at a formidable rate of around 13% and surpass $ 1 billion market by FY 2026. The country’s in-vitro fertilization market is driven by improving healthcare infrastructure and rising availability of modern healthcare facilities at affordable prices. This fact is also giving rise to medical tourism thereby propelling the in-vitro fertilization market in the country. Additionally, changing lifestyle patterns are leading to various diseases such as PCOS and other kinds of reproductive diseases. Furthermore, increasing number of single super specialty hospitals is projected to fuel the market over the next few years. Besides, growing awareness towards male infertility in the country is expected to positively influence the market over the next few years.

The India in-vitro fertilization market is segmented based on technique, product, donor, infertility, embryo, end user, and region . Based on technique, the market can be split into ICSI IVF and Non-ICSI/Traditional IVF. The ICSI IVF segment is expected to dominate the market during the forecast period. This can be ascribed to the benefits associated with this technique such as better fertilization and minimization of multi-nucleation since only one sperm and one egg is involved in this technique. Additionally, there is no acrosome reaction taking place in this technique. Based on end user, the market can be categorized into fertility clinics, hospitals and others. The fertility clinics segment is expected to dominate the market owing to the growing consumer preference for availing treatment at these facilities. Additionally, growing penetration of fertility clinics & centers chains is further expected to fuel the market growth through FY2026.

Major players operating in the India in-vitro fertilization market include Merck India (Merck KGaA), Origio India Pvt. Ltd. (Cooper Surgical), IMV India Pvt. Ltd (Hamilton Thorne, Ltd.), Thermo Fisher Scientific India Pvt. Ltd., Travancore Trade Links (Vitrolife AB), Cook Medical India, Morpheus Life Sciences Pvt. Ltd., Max Healthcare Pvt. Ltd., Olympus Medical Systems India Pvt. Ltd., Fujifilm India Private Limited and others.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and forecast the market size of India in-vitro fertilization market.
  • To classify and forecast India in-vitro fertilization market based on technique, products, donor, infertility, embryo, end user, company and regional distribution.
  • To identify drivers and challenges for India in-vitro fertilization market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India in-vitro fertilization market.
  • To conduct pricing analysis for India in-vitro fertilization market.
  • To identify and analyze the profile of leading players operating in India in-vitro fertilization market.

Click here to download the sample 

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of fertility centers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India in-vitro fertilization market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • In-vitro fertilization fertility centers, hospitals/clinics and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to in-vitro fertilization
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as fertility centers, hospitals and clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India in-vitro fertilization market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technique:
    • ICSI
    • Non-ICSI/ Traditional IVF
  • Market, By Products:
    • IVF Culture Media
    • ICSI Machine
    • IVF Incubators
    • Cryosystem
    • Others
  • Market, By Donor:
    • Fresh Non-Donor
    • Frozen Non-Donor
    • Frozen Donor
    • Fresh Donor
  • Market, By Infertility:
    • Male
    • Female
  • Market, By Embryo:
    • Fresh Embryo
    • Frozen-thawed Embryo
  • Market, By End User:
    • Fertility Clinics
    • Hospitals
    • Others
  • Market, By Region:

o   North

o   South

o   East

o   West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India in-vitro fertilization market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at

1.     Product of Interest Introduction: In-vitro Fertilization

2.    Research Methodology

3.    Impact of COVID-19 on India In-vitro Fertilization Market

4.    Executive Summary

5.    Voice of Customers/Customer Insights

6.    India In-vitro Fertilization Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.    By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF)

6.2.2.    By Products (IVF Culture Media, ICSI Machine, IVF Incubators, Cryosystem, Others)

6.2.3.     By Donor (Fresh Non-donor, Frozen Non-donor, Fresh Donor, Frozen Donor)

6.2.4.     By Infertility (Male v/s Female)

6.2.5.     By Embryo (Fresh Embryo v/s Frozen-thawed Embryo)

6.2.6.     By End User (Fertility Clinics, Hospitals, Others)           

6.2.7.    By Region (North, South, East, West)

6.2.8.    By Company                

6.3.  Product Market Map

7.    India ICSI IVF Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Products

7.2.2.     By Donor

7.2.3.     By Infertility

7.2.4.     By Embryo

7.2.5.     By End User

8.    India Non-ICSI/ Traditional IVF Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Products

8.2.2.     By Donor

8.2.3.     By Infertility

8.2.4.     By Embryo

8.2.5.     By End User

9.    Market Dynamics

9.1.     Drivers/Opportunities

9.2.     Challenges/Restraints

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

11.1.              Matrutva Yojana

11.2.              Jiyo Parsi Yojana

11.3.              Assisted Reproductive Technology Regulation Bill, 2020

11.4.              ICMR Guidelines for Sperm/Oocyte Donor

12.  List of Top 15 IVF Centers & Fertility Clinics in India

13.  India Economic Profile

14.  Competitive Landscape

14.1.    Company Profiles (Equipment/Products involved in IVF procedure manufacturer/supplier companies)

14.1.1.  Merck India (Merck KGaA)

14.1.2.  Origio India Pvt. Ltd. (Cooper Surgical)

14.1.3.  IMV India Pvt. Ltd (Hamilton Thorne, Ltd.)

14.1.4.  Thermo Fisher Scientific India Pvt. Ltd.

14.1.5.  Travancore Trade Links (Vitrolife AB)

14.1.6.  Cook Medical India

14.1.7.  Morpheus Life Sciences Pvt. Ltd.

14.1.8.  Max Healthcare Pvt. Ltd.

14.1.9.  Olympus Medical Systems India Pvt. Ltd.

14.1.10. Fujifilm India Private Limited

16. Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at
  • List of Figures:


    Figure 1: India Fertility Rate, FY2016-FY2026

    Figure 2: Proportion of Male and Female Infertility in India, FY2016-FY2026

    Figure 3: India Healthcare Expenditure, By Value (USD Million), FY2016-FY2026

    Figure 4: India Medical Tourism Valuation, By Value (USD Million), FY2016-FY2026

    Figure 5: India Newborn Mortality Rate, FY2016-FY2026

    Figure 6: India Newborn Birth Rate, FY2016-FY2026

    Figure 7: PCOS Prevalence in India, FY2016-FY2026

    Figure 8: India In-vitro Fertilization Market, By Value (USD Million), FY2016-FY2026

    Figure 9: India ICSI Market, By Value (USD Million), FY2016-FY2026

    Figure 10: India Non-ICSI/Traditional IVF Market, By Value (USD Million), FY2016-FY2026


    List of Tables:

    Table 1: List of IVF Centers in India, By Region, FY2016-FY2026

    Table 2: Top IVF Specialists in India, By Region, FY2016-FY2026

    Table 3: Number of Newborns Born in India using IVF technique, FY2016-FY2026

    Table 4: Number of Infertile Couples in Reproductive Age in India, FY2016